相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Select host restriction factors are associated with HIV persistence during antiretroviral therapy
Mohamed Abdel-Mohsen et al.
AIDS (2015)
Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4+ T Cells from Aviremic Patients
Adam M. Spivak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations
Gregory M. Laird et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Rapid Viral Rebound After 4 Years of Suppressive Therapy in a Seronegative HIV-1 Infected Infant Treated From Birth
Karina M. Butler et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation
Guochun Jiang et al.
PLOS PATHOGENS (2015)
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S. Sogaard et al.
PLOS PATHOGENS (2015)
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
Julian H. Elliott et al.
LANCET HIV (2015)
Galectin-9 Is Rapidly Released During Acute HIV-1 Infection and Remains Sustained at High Levels Despite Viral Suppression Even in Elite Controllers
Ravi Tandon et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)
Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation Report of 2 Cases
Timothy J. Henrich et al.
ANNALS OF INTERNAL MEDICINE (2014)
A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
Adam M. Spivak et al.
CLINICAL INFECTIOUS DISEASES (2014)
Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells
Chuan Wu et al.
IMMUNITY (2014)
Decreased HIV Type 1 Transcription in CCR5-Delta 32 Heterozygotes During Suppressive Antiretroviral Therapy
Charlene Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat
Nancy M. Archin et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
The Histone Deacetylase Inhibitor Vorinostat (SAHA) Increases the Susceptibility of Uninfected CD4+ T Cells to HIV by Increasing the Kinetics and Efficiency of Postentry Viral Events
Mark B. Lucera et al.
JOURNAL OF VIROLOGY (2014)
Cross-Clade Ultrasensitive PCR-Based Assays To Measure HIV Persistence in Large-Cohort Studies
Claire Vandergeeten et al.
JOURNAL OF VIROLOGY (2014)
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H. Elliott et al.
PLOS PATHOGENS (2014)
Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes
Richard Brad Jones et al.
PLOS PATHOGENS (2014)
Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing
Datsen George Wei et al.
PLOS PATHOGENS (2014)
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A. Rasmussen et al.
LANCET HIV (2014)
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
Zichong Li et al.
NUCLEIC ACIDS RESEARCH (2013)
Calcium/Calcineurin Synergizes with Prostratin to Promote NF-κB Dependent Activation of Latent HIV
Jonathan K. Chan et al.
PLOS ONE (2013)
Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection
Stephanie Jost et al.
RETROVIROLOGY (2013)
Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease
Yuko Kurose et al.
BMC NEPHROLOGY (2013)
Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
Steven A. Yukl et al.
PLOS PATHOGENS (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
Michelle K. Gleason et al.
BLOOD (2012)
Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection
Shokrollah Elahi et al.
BLOOD (2012)
Lower-Sensitivity and Avidity Modifications of the Vitros Anti-HIV 1+2 Assay for Detection of Recent HIV Infections and Incidence Estimation
Sheila M. Keating et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro
Brian A. DeChristopher et al.
NATURE CHEMISTRY (2012)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo
Satish K. Pillai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Reactivation of Latent HIV-1 by Inhibition of BRD4
Jian Zhu et al.
CELL REPORTS (2012)
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21
Huabiao Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
In vivo, in vitro, and in silico analysis of methylation of the HIV-1 provirus
Leonard Chavez et al.
METHODS (2011)
Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry
Shuguang Bi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
Steven A. Yukl et al.
AIDS (2010)
Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency
Moises Perez et al.
CURRENT HIV RESEARCH (2010)
Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia
Junya Kuroda et al.
MOLECULAR CANCER RESEARCH (2010)
Galectin-9 trafficking regulates apical-basal polarity in Madin-Darby canine kidney epithelial cells
Rashmi Mishra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8+ T Cell Response
Sharvan Sehrawat et al.
PLOS PATHOGENS (2010)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection
Sophie Reuse et al.
PLOS ONE (2009)
Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
Masako Seki et al.
CLINICAL IMMUNOLOGY (2008)
Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1
Nozomu Nishi et al.
GLYCOBIOLOGY (2008)
Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices
Atsuya Nobumoto et al.
GLYCOBIOLOGY (2008)
Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways
Shuguang Bi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
Keiko Nagahara et al.
JOURNAL OF IMMUNOLOGY (2008)
Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts
Feng Wang et al.
TRANSPLANT IMMUNOLOGY (2008)
Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts
Masako Seki et al.
ARTHRITIS AND RHEUMATISM (2007)
The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft
Feng Wang et al.
CELLULAR IMMUNOLOGY (2007)
Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma
Shigeki Katoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms
M Baba et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Development of highly stable galectins: Truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins
N Nishi et al.
FEBS LETTERS (2005)
Prostratin antagonizes HIV latency by activating NF-κB
SA Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Q Yu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
K Stopak et al.
MOLECULAR CELL (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
A Jordan et al.
EMBO JOURNAL (2003)
Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death
M Lanteri et al.
GLYCOBIOLOGY (2003)
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
AM Sheehy et al.
NATURE MEDICINE (2003)
Galectinomics: finding themes in complexity
DNW Cooper
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART
J Kulkosky et al.
BLOOD (2001)
Controlling the false discovery rate in behavior genetics research
Y Benjamini et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
分享论文
